Upexi Inc
UPXI2.040USD
0.000
Close 12/15, 16:00（ET）Quotes delayed by 15 min
120.14MMarket Cap
0.07P/E TTM
More Details of Upexi Inc Company
Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.
Upexi Inc Info
Ticker SymbolUPXI
Company nameUpexi Inc
IPO dateJun 24, 2021
CEOMarshall (Allan)
Number of employees59
Security typeOrdinary Share
Fiscal year-endJun 24
Address3030 Rocky Point Drive
CityTAMPA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33607
Phone17013535425
Websitehttps://upexi.com/
Ticker SymbolUPXI
IPO dateJun 24, 2021
CEOMarshall (Allan)
Company Executives of Upexi Inc
Name
Name/Position
Position
Shareholding
Change
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.51M
+899.43%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
685.37K
+17.08%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
589.14K
+68.74%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
100.00K
--
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Shareholding
Change
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.51M
+899.43%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
685.37K
+17.08%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
589.14K
+68.74%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
100.00K
--
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q1
By BusinessUSD
Name
Revenue
Proportion
Internally manufactured
9.26M
62.48%
Contract manufactured
2.79M
18.80%
Purchased as finished goods
2.78M
18.73%
By RegionUSD
Name
Revenue
Proportion
United States of America
14.57M
98.25%
Other
259.57K
1.75%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Internally manufactured
9.26M
62.48%
Contract manufactured
2.79M
18.80%
Purchased as finished goods
2.78M
18.73%
Shareholding Stats
Updated: Sat, Nov 22
Updated: Sat, Nov 22
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Polar Asset Management Partners Inc.
7.91%
Samara Special Opportunities
7.16%
GSR Growth Investments LP
4.25%
Marshall (Allan)
2.39%
Alyeska Investment Group, L.P.
1.98%
Other
76.30%
Shareholders
Shareholders
Proportion
Polar Asset Management Partners Inc.
7.91%
Samara Special Opportunities
7.16%
GSR Growth Investments LP
4.25%
Marshall (Allan)
2.39%
Alyeska Investment Group, L.P.
1.98%
Other
76.30%
Shareholder Types
Shareholders
Proportion
Hedge Fund
11.97%
Corporation
11.41%
Investment Advisor
8.44%
Individual Investor
6.08%
Research Firm
2.38%
Investment Advisor/Hedge Fund
1.36%
Bank and Trust
0.45%
Venture Capital
0.05%
Other
57.86%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
60
18.50M
31.42%
+11.94M
2025Q2
46
10.18M
21.50%
+7.63M
2025Q1
42
311.78K
28.56%
-35.31K
2024Q4
42
307.62K
23.29%
-32.82K
2024Q3
40
303.51K
29.16%
-55.91K
2024Q2
40
319.39K
30.68%
-45.58K
2024Q1
42
328.34K
32.32%
-46.59K
2023Q4
42
319.26K
31.43%
-34.26K
2023Q3
40
369.15K
37.28%
-46.01K
2023Q2
44
368.80K
38.85%
-28.58K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Samara Special Opportunities
4.53M
7.69%
+4.53M
--
Aug 29, 2025
GSR Growth Investments LP
2.31M
3.92%
-1.00
-0.00%
Jun 30, 2025
Marshall (Allan)
1.51M
2.57%
+1.36M
+899.43%
Jul 16, 2025
Rudick (Brian Benjamin)
838.60K
1.42%
+400.00K
+91.20%
Jul 16, 2025
MMCAP Asset Management
12.94M
21.98%
+12.94M
--
Jul 16, 2025
The Vanguard Group, Inc.
500.84K
0.85%
+500.84K
--
Jun 30, 2025
Salkind (Gene)
585.37K
0.99%
+220.24K
+60.32%
Jul 16, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Date
Type
Ratio
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
FAQs
Who are the top five shareholders of Upexi Inc?
The top five shareholders of Upexi Inc are:
Samara Special Opportunities holds 4.53M shares, accounting for 7.69% of the total shares.
GSR Growth Investments LP holds 2.31M shares, accounting for 3.92% of the total shares.
Marshall (Allan) holds 1.51M shares, accounting for 2.57% of the total shares.
Rudick (Brian Benjamin) holds 838.60K shares, accounting for 1.42% of the total shares.
MMCAP Asset Management holds 12.94M shares, accounting for 21.98% of the total shares.
Samara Special Opportunities holds 4.53M shares, accounting for 7.69% of the total shares.
GSR Growth Investments LP holds 2.31M shares, accounting for 3.92% of the total shares.
Marshall (Allan) holds 1.51M shares, accounting for 2.57% of the total shares.
Rudick (Brian Benjamin) holds 838.60K shares, accounting for 1.42% of the total shares.
MMCAP Asset Management holds 12.94M shares, accounting for 21.98% of the total shares.
What are the top three shareholder types of Upexi Inc?
The top three shareholder types of Upexi Inc are:
Polar Asset Management Partners Inc.
Samara Special Opportunities
GSR Growth Investments LP
Polar Asset Management Partners Inc.
Samara Special Opportunities
GSR Growth Investments LP
How many institutions hold shares of Upexi Inc (UPXI)?
As of 2025Q3, 60 institutions hold shares of Upexi Inc, with a combined market value of approximately 18.50M, accounting for 31.42% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 9.93%.
What is the biggest source of revenue for Upexi Inc?
In FY2025, the Internally manufactured business generated the highest revenue for Upexi Inc, amounting to 9.26M and accounting for 62.48% of total revenue.
